Acute-on-chronic liver failure: extracorporeal liver assist devices
Authors:
- Tarek I HassaneinTHTarek I Hassanein
- Robert R SchadeRSRobert R Schade
- Iryna S HepburnIHIryna S Hepburn
- 1 April 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 17 (2) , 195-203
Abstract
Acute-on-chronic liver failure (ACLF), a syndrome precipitated by acute liver injury in patients with advanced cirrhosis, is associated with multiorgan dysfunction and high rates of mortality. Liver support systems have been developed in an attempt to improve survival of patients with ACLF by providing a bridge until recovery of the native liver function. Nonbiological devices such as molecular adsorbent recirculating system (MARS) and fractionated plasma separation and adsorption (Prometheus) are effective in improving severe hepatic encephalopathy and cholestasis, have good safety and tolerability profiles and are frequently employed in patients with ACLD; however, randomized controlled trials (RCTs) failed to show improvement in survival. Biologic devices that incorporate hepatic cells in bioreactors are also under development. Recent data from pilot studies suggested improvement in survival rates in some groups of patients with ACLF; however, their effect on patient survival in RCT is still unknown. Liver support systems are safe and well tolerated when used in management of patients with ACLF. Their use should continue in controlled clinical trials to explore their role in bridging patients to liver transplantation or recovery in well defined patient groups.Keywords
This publication has 59 references indexed in Scilit:
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease ProgressionGastroenterology, 2010
- Liver support systems todayOrvosi Hetilap, 2009
- Pig Liver Xenotransplantation as a Bridge to Allotransplantation: Which Patients Might Benefit?Transplantation, 2009
- Liver transplantation for acute-on-chronic liver failureHepatology International, 2009
- Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failureCritical Care, 2009
- Future of bioartificial liver supportWorld Journal of Gastrointestinal Surgery, 2009
- Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: A pilot studyLiver Transplantation, 2006
- In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separationJournal of Hepatology, 2005
- Prometheus® – a new extracorporeal system for the treatment of liver failure☆Journal of Hepatology, 2003
- Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled studyHepatology, 2002